TCTerence J. Colgan

Terence J. Colgan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Terence J. Colgan has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew A. Renshaw

    9 shared publications
  • Dina R. Mody

    9 shared publications
  • Diane D. Davey

    From the Department of Pathology, Baptist Hospital of Miami, Miami, Fla (Dr Renshaw); College of American Pathologists, Northfield, Ill (Dr Wang); Department of Pathology, The Methodist Hospital, Houston, Tex (Dr Mody); Department of Pathology, Massachusetts General Hospital, Boston (Dr Wilbur); Department of Pathology and Laboratory Medicine, University of Kentucky Hospital, Lexington (Dr Davey)

    4 shared publications
  • Diane D. Davey

    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536-0298, USA

    3 shared publications
  • Dina R Mody

    3 shared publications
  • Edward Wang

    From the Department of Pathology, Baptist Hospital of Miami, Miami, Fla (Dr Renshaw); the Department of Pathology, The Methodist Hospital, Houston, Tex (Dr Mody); the College of American Pathologists, Northfield, Ill (Dr Wang and Ms Haja); and the Department of Pathology, Mount Sinai Hospital, Toronto, Ontario (Dr Colgan)

    3 shared publications

Latest Publications

  • Other Cervical Neoplasms

    by Martin C. Chang, Terence J. Colgan

  • A validation study of the FocalPoint GS imaging system for gynecologic cytology screening

    by Terence J. Colgan, Nereo Bon, Susan Clipsham, Geoffrey Gardiner, Jeff Sumner, Virginia Walley, C. Meg McLachlin

    BACKGROUND: Studies of the performance of the automated FocalPoint Guided Screening (FPGS) imaging system in gynecologic cytology screening relative to manual screening have yielded conflicting results. In view of this uncertainty, a validation study of the FPGS was conducted before its potential adoption in 2 large laboratories in Ontario.METHODS: After an intense period of laboratory training, a cohort of 10,233 current and seeded abnormal slides were classified initially by FPGS. Manual screening and reclassification blinded to the FPGS results were then performed. Any adequacy and/or cytodiagnostic discrepancy between the 2 screening methods subsequently was resolved through a consensus process (truth). The performance of each method's adequacy and cytodiagnosis vis‐a‐vis the truth was established. The sensitivity and specificity of each method at 4 cytodiagnostic thresholds (atypical squamous cells of undetermined significance or worse [ASC‐US+], low‐grade squamous intraepithelial lesion or worse [LSIL+], high‐grade squamous intraepithelial lesion or worse [HSIL+], and carcinoma) were compared. The false‐negative rate for each cytodiagnosis was determined.RESULTS: The performance of FPGS in detecting carcinoma, HSIL+, and LSIL+ was no different from the performance of manual screening, but the false‐negative rates for LSIL and ASC‐US were higher with FPGS than with manual screening.CONCLUSIONS: The results from this validation study in the authors' laboratory environment provided no evidence that FPGS has diagnostic performance that differs from manual screening in detecting LSIL+, HSIL+, or carcinoma. Cancer (Cancer Cytopathol) 2013;121:189–196. © 2013 American Cancer Society.


  • Superficially Invasive Squamous Cell Carcinoma of the Uterine Cervix

    by Alice Lytwyn, Richard Zaino, Terence J. Colgan, Christopher Otis

    A variety of terms have been used over the years to define a set of early invasive squamous carcinomas of the uterine cervix that can be treated by local excision only. The Lower Anogenital Squamous Terminology consensus group has recommended that the term “superficially invasive squamous cell carcinoma” (SISCCA) be used for any genital invasive squamous carcinoma that can be managed by local excision only. The definition of SISCCA varies by genital site. A diagnosis of SISCCA of the uterine cervix requires that the invasive lesion was not visualized, has been completely excised, has a depth of invasion no more than 3 mm, and has a horizontal extent of no more than 7 mm. Lymphovascular invasion may or may not be present and should be noted. Superficially invasive squamous cell carcinoma of the uterine cervix is synonymous with an International Federation of Gynecology and Obstetrics stage IA1 carcinoma. This review addresses morphologic challenges that can be seen in the diagnosis of SISCCA including the identification of early invasion, measurements of depth and horizontal extent, and the assessment of circumferential involvement and margin status.


  • Papillary Syncytial Metaplasia of Fallopian Tube Endometriosis: A Potential Pitfall in the Diagnosis of Serous Tubal Intraepithelial Carcinoma

    by Harkiran Kaur, Elyse Levinsky, Terence J. Colgan

    Histopathologic diagnosis of tubal intraepithelial carcinoma (TIC) has emerged as a significant challenge in the last few years. The avoidance of pitfalls in the diagnosis of TIC is crucial if a better understanding of its natural history and outcome is to be achieved. Herein, we present a case of a 52-year-old woman who underwent a risk-reducing salpingo-oophorectomy procedure. Histologic examination of a fallopian tube demonstrated a focus of atypical epithelial proliferation, which was initially considered to be a TIC. Complete study of the case indicated that the focus was, in fact, papillary syncytial metaplasia of tubal mucosal endometriosis. Papillary syncytial metaplasia may resemble TIC and should be considered in cases of proliferative lesions of the tubal epithelium.


  • The Practice of Pathology in Canada: Decreasing Pathologist Supply and Uncertain Outcomes

    by Terence J. Colgan, Laurette Geldenhuys

    Context .—Pathology organizations in the United States are preparing for a new era of health care reform. Trends in the supply of pathologists in Canada's managed care system may provide some useful insights in any analysis and projection of future pathologist needs in the United States. Objective .—In this study, population-based Canadian databases were used to devise a parameter for physician supply, cancer cases per physician. The trend in this supply parameter for pathologists was compared to that for radiation oncologists. Design .—The number of Canadian pathologists and radiation oncologists and the annual number of new cancer cases in each of 2 years, 1999 and 2009, were extracted from reliable databases. Cancer cases per pathologist and oncologist were calculated, and relative trends in supply of physicians in both specialties were identified. Results .—The annual number of new cancer cases increased from 129 300 to 171 000 from 1999 to 2009. The absolute numbers of both pathologists and oncologists also increased in this time period. However, while the increase in the number of radiation oncologists led to an 8.2% decrease in cancer cases per radiation oncologist, the modest increase in the number of pathologists led to an increase of 17.1% in cancer cases per pathologist. Conclusions .—There is a trend toward a decreasing supply of Canadian pathologists relative to that of cancer demands. This finding confirms an earlier population-based study showing a decreased supply relative to population and number of clinical physicians. It is uncertain whether this decreased supply is a result of appropriate application of new, efficient methods or whether health care has been rationed or adversely impacted. Outcome measures to monitor Canadian pathology practice quality are clearly needed.


  • Open Access

    The 2006 consensus guidelines for the management of women with abnormal cervical screening tests

    by Terence J. Colgan

    The American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for the management of women with abnormal cervical screening test results is a powerful, evidence‐based document representing an advance in the consistent treatment of women with cervical abnormalities. Nevertheless, the complexity of the guidelines is an outstanding issue, compliance with the guidelines is problematic in some areas, and there is a growing recognition of the deficiencies of colposcopy. In light of these challenges, the cytopathology community has an opportunity to play an active role in integrating data, defining risk, and recommending proper management for women screened for cervical cancer. Cancer (Cancer Cytopathol) 2010. © 2010 American Cancer Society.


  • Open Access

    Predictors of malignancy in thyroid fine‐needle aspirates “cyst fluid only” cases

    by Mohammad Jaragh, V. Bessie Carydis, Christina MacMillan, Jeremy Freeman, Terence J. Colgan

    BACKGROUND: A recent consensus conference on thyroid fine‐needle aspiration (FNA) cytology concluded that specimens with abundant histiocytes and few or no follicular cells should be interpreted as “cyst fluid only,” under the category of “nondiagnostic.” The purpose of the current study was to identify any cytomorphologic characteristics in this type of specimen that are predictive of an underlying malignancy.METHODS: Thyroid FNA cases with a report of cyst fluid only and a follow‐up thyroidectomy specimen were identified during a 3‐year period. A blinded retrospective review of 6 morphologic features in the thyroid FNA specimens was conducted. These review findings were then correlated with the histopathologic diagnosis (benign or malignant).RESULTS: Of the 76 cyst fluid only cases with subsequent thyroidectomy, 10 cases had an ipsilateral diagnosis of papillary carcinoma measuring ≥1.0 cm. There was no association found between the number or amount of acute inflammatory cells, blood, colloid, macrophages, and pigmented macrophages and the histologic outcome. In only 4 of the 10 cases with a malignant outcome was the specimen assessed as being truly inadequate on retrospective review, and in 1 of these cases, the cytology was suggestive of malignancy.CONCLUSIONS: The only cytomorphologic characteristic found to be predictive of subsequent malignancy in cyst fluid only cases was the presence of follicular epithelium with atypical or suspicious features. Therefore, cases containing atypical epithelial cells should not be categorized as nondiagnostic or cyst fluid only, but rather diagnosed as atypical or suspicious. Cancer (Cancer Cytopathol) 2009. © 2009 American Cancer Society.


  • Chordoma arising in a mature cystic teratoma of the ovary: A case report

    by Facundo Las Heras, Kenneth P.H. Pritzker, Terence J. Colgan